Physician profile
Alan Davidson
NPI 1245339126
$8,293.47
in general payments reported to CMS, 2019-2025
39 companies · $1,044 in 2025
The $1,044 reported for 2025 was more than what 87% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,227 · 2020: $794 · 2021: $991 · 2022: $1,365 · 2023: $1,383 · 2024: $1,489 · 2025: $1,044.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,916.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,916.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,166.77 | 2019-2025 | |
| Abbvie INC. | $1,121.94 | 2021-2025 | Qulipta, Vraylar, Linzess |
| Novo Nordisk INC | $964.92 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $847.96 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Lilly USA, LLC | $798.75 | 2020-2025 | Jardiance, Mounjaro, Zepbound |
| Amgen INC. | $482.13 | 2019-2025 | Prolia, Evenity, Otezla |
| Sanofi-Aventis U.S. LLC | $413.71 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $257.29 | 2019-2025 | Jardiance, Tradjenta |
| Exact Sciences Corporation | $241.76 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Paratek Pharmaceuticals, INC. | $219.32 | 2022-2025 | Nuzyra, Xhance |
| Takeda Pharmaceuticals U.S.A., INC. | $204.31 | 2019-2024 | Trintellix |
| Glaxosmithkline, LLC. | $200.00 | 2020-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbott Laboratories | $164.81 | 2022-2025 | Freestyle Libre 3 |
| Sumitomo Pharma America, INC. | $114.59 | 2023-2025 | Gemtesa |
| Amarin Pharma, INC. | $111.96 | 2019-2022 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Davidson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.